[1]
|
D. Raoux, S. Duband, F. Forest, B. Trombert, M. L. Chambonnière, J. Dumollard, A. Khaddage, A. Gentil-Perret and M. Péoch, “Primary Central Nervous System Lymphoma: Immunohistochemical Profile and Prognostic Significance,” Neuropathology, Vol. 30, No. 3, 2010, pp. 232-240.
|
[2]
|
D. L. Commins, “Pathology of Primary Central Nervous System Lymphoma,” Neurosurgical Focus, Vol. 21, No. 5, 2006, pp. E2.
|
[3]
|
N. P. Mendenhall, T. L. Thar, O. F. Agee, et al., “Primary Lymphoma of the Central Nervous System. Computerized Tomography Scan Characteristics and Treatment Results for 12 Cases,” Cancer, Vol. 52, No. 1983, pp. 1993-2000.
doi:10.1002/1097-0142(19831201) 52:11<1993::AID-CNCR2820521104>3.0.CO;2-C
|
[4]
|
N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini and K. C. Gatter, “A Revised Europe and American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group,” Blood, Vol. 84, No. 5, 1994, pp. 1361-1392.
|
[5]
|
P. Isaacson and D. H. Wright, “Malignant Lymphoma of Mucosa-Associated Lymphoid Tissue. A Distinctive Type of B-Cell Lymphoma,” Cancer, Vol. 52, 1983, pp. 1410-1416.
doi:10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3
|
[6]
|
S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele and J. W. Vardiman, “WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues,” 4th Edition, IARC Press, Lyon, 2008.
|
[7]
|
P. H. Tu, C. Giannini, A. R. Judkins, J. M. Schwalb, R. Burack, B. P. O’Neill, A. T. Yachnis, P. C. Burger, B. W. Scheithauer and A. Perry, “Clinicopathologic and Genetic Profile of Intracranial Marginal Zone Lymphoma: A Primary Low-Grade CNS Lymphoma That Mimics Meningioma,” Journal of Clinical Oncology, Vol. 23, No. 24, 2005, pp. 5718-5727. doi:10.1200/JCO.2005.17.624
|
[8]
|
T. Itoh, M. Shimizu, K. Kitami, K. Kamata, K. Mitsumori, M. Fujita, A. Ohnishi and K. Nagashima, “Primary Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type in the CNS,” Neuropathology, Vol. 21, No. 3, 2001, pp. 174-180.
doi:10.1046/j.1440-1789.2001.00392.x
|
[9]
|
I. Park, J. Huh, J. H. Kim, S. W. Lee, M. H. Ryu and Y. K. Kang, “Primary Central Nervous System Marginal Zone B-Cell Lymphoma of the Basal Ganglia Mimicking Low-Grade Glioma: A Case Report and Review of the Literature,” Clinical Lymphoma Myeloma, Vol. 8, No. 5, 2008, pp. 305-308. doi:10.3816/CLM.2008.n.043
|
[10]
|
A. Papanicolau-Sengo, J. Wang-Rodriguez, W. Huan-You, R. Lee, A. Wong, L. A. Hansen, S. Sepi Mahooti and H. H. Rashidi, “Rare Case of a Primary Non-Dural Central Nervous System Low Grade B-Cell Lymphoma and Literature Review,” International Journal of Clinical and Experimental Pathology, Vol. 5, No. 1, 2012, pp. 89-95.
|
[11]
|
G. N. Fuller and J. C. Goodman, “Practical Review of Neuropathology,” Lippincott, Williams & Wilkins, Philadelphia, 2001, pp. 57-58.
|
[12]
|
S. Kumar, D. Kumar, E. P. Kaldjian, et al., “Primary Low-Grade B-Cell Lymphoma of the Dura: A Mucosa Associated Lymphoid Tissue-Type Lymphoma,” The American Journal of Surgical Pathology, Vol. 21, No. 1, 1997, pp. 81-87.
doi:10.1097/00000478-199701000-00009
|
[13]
|
A. C. Wotherspoon, C. Doglioni, T. C. Diss, et al., “Regression of Primary Low Grade B-Cell Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type after Eradication of Helicobacter Pylori,” Lancet, Vol. 342, 1993, pp. 575-577. doi:10.1016/0140-6736(93)91409-F
|
[14]
|
M. Lecuit, E. Abachin, A. Martin, et al., “Immunoproliferative Small Intestinal Disease Associated with Campylobacter Jejuni,” The New England Journal of Medicine, Vol. 350, No. 8871, 2004, pp. 239-248.
doi:10.1056/NEJMoa031887
|
[15]
|
A. J. Ferreri, M. Ponzoni, M. Guidoboni, et al., “Bacteria-Eradicating Therapy with Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial,” Journal of the National Cancer Institute, Vol. 98, No. 19, 2006, pp. 1375-1382. doi:10.1093/jnci/djj373
|
[16]
|
C. Garbe, H. Stein, D. Dienemann, et al., “Borrelia Burgdorferi-Associated Cutaneous B Cell Lymphoma: Clinical and Immunohistologic Characterization of Four Cases,” Journal of the American Academy of Dermatology, Vol. 24, No. 4, 1991, pp. 584-590.
doi:10.1016/0190-9622(91)70088-J
|
[17]
|
K. Lewis, C. Vandervelde, R. Grace, et al., “Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma in 2 Patients with Sjogren’s Syndrome: Clinical and Sonographic Features with Pathological Correlation,” Journal of Clinical Ultrasound, Vol. 35, No. 2, 2007, pp. 97-101. doi:10.1002/jcu.20280
|
[18]
|
R. Wozniak, L. Beckwith, H. Ratech, et al., “Maltoma of the Thyroid in a Man with Hashimoto’s Thyroiditis,” The Journal of Clinical Endocrinology & Metabolism, Vol. 84, No. 4, 1999, pp. 1206-1209. doi:10.1210/jc.84.4.1206
|
[19]
|
A. Sanjeevi, J. Krishnan, P. R. Bailey, et al., “Extranodal Marginal Zone B-Cell Lymphoma of Malt Type Involving the Cavernous Sinus,” Leukemia & Lymphoma, Vol. 42, No. 5, 2001, pp. 1133-1137.
doi:10.3109/10428190109097736
|
[20]
|
T. Akagi, M. Motegi, A. Tamura, et al., “A Novel Gene, MALT1 at 18q21, Is Involved in t(11;18)(q21;q21) Found in Low Grade B-Cell Ymphoma of Mucosa Associated Lymphoid Tissue,” Oncogene, Vol. 18, No. 42, 1999, pp. 5785-5794. doi:10.1038/sj.onc.1203018
|
[21]
|
B. Maes and C. de Wolf-Peeters, “Marginal Zone B Cell Lymphoma: An Update on Recent Advances,” Histopathology, Vol. 40, No. S3, 2002, pp. 117-126.
doi:10.1046/j.1365-2559.2002.01360.x
|
[22]
|
L. Pasqualucci, O. Bereschenko, H. Niu, et al., “Molecular Pathogenesis of Non-Hodgkin’s Lymphoma: The Role of Bcl-6,” Leukemia & Lymphoma, Vol. 44, No. S3, 2003, pp. S5-S12. doi:10.1080/10428190310001621588
|
[23]
|
J. Dierlamm, S. Pittaluga, M. Stul, et al., “BCL6 Gene Rearrangements Also Occur in Marginal Zone B-Cell Lymphoma,” British Journal of Haematology, Vol. 98, No. 3, 1997, pp. 719-725.
doi:10.1046/j.1365-2141.1997.2703087.x
|
[24]
|
N. Kambham, Y. Chang and A. Y. Matsushima, “Primary Lowgrade B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Arising in Dura,” Clinical Neuropathology, Vol. 17, 1998, pp. 311-317.
|
[25]
|
M. Estevez, C. Chu, M. Pless, “ Small B-cell lym-phoma presenting as diffuse dural thickening with cranial neuropathies,” Journal of Neuro-Oncology, Vol. 59, No. 3, 2002, pp. 243-237.
doi:10.1023/A:1019913611512
|
[26]
|
A. Garcia-Serra, M. N. Price, R. W. Hinerman, et al., “Management of Neurotropic Low-Grade B-Cell Lymphoma: Report of Two Cases,” Head & Neck, Vol. 25, No. 11, 2003, pp. 972-976. doi:10.1002/hed.10311
|
[27]
|
N. L. Lehman, D. S. Horoupian, R. A. Warnke, et al., “Dural Marginal Zone Lymphoma with Massive Amyloid Deposition: Rare Low-Grade Primary Central Nervous System B-Cell Lymphoma. Case Report,” Journal of Neurosurgery, Vol. 96, No. 2, 2002, pp. 368-372.
doi:10.3171/jns.2002.96.2.0368
|
[28]
|
W. Razaq, A. Goel, A. Amin and M. L. Grossbard, “Primary Central Nervous System Mucosa-Associated Lymphoid Tissue Lymphoma: Report and Literature Review,” Clinical Lymphoma Myeloma and Leukemia, Vol. 9, No. 3, 2009, pp. E5-E9. doi:10.3816/CLM.2009.n.052
|